A
Abingworth Portfolio holdings
AUM
$307M
This Quarter Return
+20.14%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
–
AUM
$220M
AUM Growth
+$220M
(-6.3%)
Cap. Flow
-$56M
Cap. Flow
% of AUM
-25.42%
Top 10 Holdings %
Top 10 Hldgs %
95.12%
Holding
19
New
2
Increased
1
Reduced
3
Closed
3
Top Buys
1 |
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
|
$10.2M |
2 |
INNL
Innocoll Holdings plc Ordinary Shares
INNL
|
$7.95M |
3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$866K |
Top Sells
1 |
Supernus Pharmaceuticals
SUPN
|
$27.8M |
2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$27.5M |
3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$13.2M |
4 |
CEMP
Cempra, Inc.
CEMP
|
$3.28M |
5 |
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
|
$2.87M |
Sector Composition
1 | Healthcare | 86.34% |